Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
  1. 8-K Event Other events
  2. 424B5 Offering Prospectus
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 8-K Event Results of operations
  6. 10-Q Report Quarterly Report
  7. 424B3 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. 8-K Event Executive or director change
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 8-K Event Other events
  12. EFFECT Other Notice of Effectiveness
  13. 424B3 Offering Prospectus
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. UPLOAD Other SEC-generated Letter
  16. S-3 Offering Registration Statement
  17. 8-K Event Agreement ended · Bylaws or fiscal year change · Shareholder vote results
  18. SCHEDULE 13D/A Stake Beneficial Ownership Report
  19. 4/A Insider Changes in Ownership
  20. EFFECT Other Notice of Effectiveness

Page 6 of 42 · 833 filings